文献速递耳科与耳神经

鼓室内注射地塞米松治疗突发性感音神经性听力损失:系统综述与Meta分析

Intratympanic dexamethasone in sudden sensorineural hearing loss: A systematic review and meta-analysis.
PubMed 文献 · Laryngoscope · 2016-11-15

该系统综述与Meta分析纳入8项随机对照临床试验,评估鼓室内注射地塞米松(ITD)治疗突发性感音神经性听力损失(SSNHL)的疗效与副作用。Meta分析未能发现ITD与替代治疗之间存在统计学显著差异(比值比=0.39,95%可信区间=0.11-1.27)。ITD的副作用情况良好,未记录到严重不良事件。

要点

  • Meta分析未能发现ITD与替代治疗在SSNHL疗效上存在统计学显著差异(OR=0.39,95%CI=0.11-1.27)。
  • ITD的副作用情况良好,未记录到严重不良事件。
  • 8项随机对照试验中3项存在高偏倚风险,且发现存在显著异质性。

核心结论

  • 没有足够的科学证据支持ITD与替代治疗对SSNHL的疗效存在差异。
  • 作者建议开展更大规模的随机对照临床试验以确定ITD相比口服类固醇治疗的疗效。
  • 作者鼓励研究设计转向非劣效性或优效性研究。
  • 避免全身皮质类固醇治疗,尤其在脆弱人群中,应成为该领域未来研究的理由。

研究设计与样本

  • 系统综述与Meta分析,检索Cochrane、Embase和MEDLINE电子数据库(1950年1月至2014年8月,2014年11月10日更新)。
  • 纳入8项关于SSNHL的随机对照临床试验(RCCTs),使用PRISMA流程图与指南,采用Cochrane协作工具评估偏倚风险。

主要发现

  • 8项研究中3项存在高偏倚风险,发现存在显著异质性。
  • Meta分析未能检测到ITD与替代治疗之间存在统计学显著差异(比值比=0.39,95%可信区间=0.11-1.27)。
  • ITD的副作用情况良好,未记录到严重不良事件。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 8项研究中3项存在高偏倚风险。
  • 发现存在显著异质性。
  • 作者建议开展更大规模的随机对照临床试验以确定ITD相比口服类固醇治疗的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic dexamethasone has demonstrated conclusive benefits in reversing sudden sensorineural hearing loss (SSNHL) despite considerable number of potential side effects. In contrast, the intratympanic route of steroid administration averts several possible complications. This study aims to examine the literature to delineate the efficacy and side effect of intratympanic dexamethasone (ITD) injection for the treatment of SSNHL. DATA SOURCE: Cochrane, Embase, and MEDLINE electronic databases from January 1950 to August 2014, with an update performed on November 10, 2014. REVIEW METHODS: Systematic review and meta-analysis of randomized controlled clinical trials (RCCTs), using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram and guidelines. Quality assessment was performed using The Cochrane Collaboration Tool for Assessing Risk of Bias. RESULTS: Eight RCCTs on SSNHL were included Three of the eight studies had high risk of bias. Substantial heterogeneity was found. The meta-analysis failed to detect statistically significant difference between ITD and alternative treatment (odds ratio = 0.39, 95% credible intervals = 0.11-1.27). The side-effects profile was favorable for ITD. No serious adverse events were recorded. CONCLUSION: There is no sufficient scientific evidence to support a difference between ITD and alternative therapy for SSNHL. We recommend larger RCCTs to determine the effectiveness of ITD compared to oral steroid therapy. We encourage a shift in study design selection toward noninferiority or superiority studies. Avoiding systemic corticotherapy, especially in vulnerable populations, should be the rationale for future research in the field. Laryngoscope, 127:1897-1908, 2017.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. El Sabbagh NG, Sewitch MJ, Bezdjian A, et al. Intratympanic dexamethasone in sudden sensorineural hearing loss: A systematic review and meta-analysis. Laryngoscope. 2016. PMID: 27861924. doi:10.1002/lary.26394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。